Danielle Gumina
Physician Assistant · Naples, FLNPI 1760728687
Payments from drug & device makers
Across 283 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$669
- Amgen$519
- Novartis$488
- Xeris Pharmaceuticals, Inc.$468
- AstraZeneca$421
- Corcept Therapeutics$397
- plus $3K from 25 others
What the payments were for
- Food & beverage$5,902100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 36 | $669 |
| Amgen | 31 | $519 |
| Novartis | 24 | $488 |
| Xeris Pharmaceuticals, Inc. | 23 | $468 |
| AstraZeneca(2 entities) | 13 | $421 |
| Corcept Therapeutics | 24 | $397 |
| Boehringer Ingelheim | 13 | $326 |
| Novo Nordisk | 16 | $298 |
| Dexcom, Inc. | 10 | $290 |
| AbbVie | 11 | $261 |
| IBSA Pharma Inc. | 12 | $242 |
| Almatica Pharma LLC | 10 | $206 |
| Bayer | 10 | $199 |
| Recordati_rare_diseases_inc. | 7 | $180 |
| Radius Health, Inc. | 7 | $146 |
| Sanofi-aventis U.S. LLC | 5 | $129 |
| Amneal Pharmaceuticals LLC | 5 | $114 |
| Esperion Therapeutics, Inc. | 5 | $111 |
| Tandem Diabetes Care, Inc. | 5 | $73 |
| Vivus LLC | 3 | $69 |
| BETA Bionics, Inc. | 2 | $51 |
| Acella Pharmaceuticals, LLC | 2 | $38 |
| Sandoz | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Sequel Med Tech, LLC | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Abbott | 1 | $25 |
| Averitas Pharma Inc. | 1 | $21 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
- DEXCOM G7 GSS (161)$105
How this compares
$5,902 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 550 | $579,084 |
| KorlymMifepristone | 13 | $240,146 |
| OzempicSemaglutide | 139 | $183,577 |
| TrulicityDulaglutide | 47 | $63,473 |
| Repatha SureclickEvolocumab | 68 | $54,000 |
| JardianceEmpagliflozin | 35 | $48,490 |
| Tresiba Flextouch U-200Insulin Degludec | 67 | $44,251 |
| Xigduo XrDapaglifloz Propaned/Metformin | 26 | $29,123 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 21 | $23,520 |
| Tresiba Flextouch U-100Insulin Degludec | 72 | $23,457 |
| VascepaIcosapent Ethyl | 42 | $21,977 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 38 | $20,591 |
| RybelsusSemaglutide | 15 | $18,846 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 13 | $17,657 |
| SynthroidLevothyroxine Sodium | 172 | $17,154 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $669 | $642,557597 claims |
| Corcept TherapeuticsKorlym | $397 | $240,14613 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $298 | $204,979165 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy | $326 | $84,69770 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $129 | $17,65713 claims |
| AbbVieSynthroid | $261 | $17,154172 claims |
| AstraZenecaFarxiga | $421 | $13,25911 claims |
| IBSA Pharma Inc.Tirosint | $242 | $8,02332 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $114 | $2,633268 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Naples
- Andrew ShirlenNaples$44K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.